Cargando…
Non-steroidal anti-inflammatory drugs among chronic kidney disease patients: an epidemiological study
BACKGROUND: Non-steroidal anti-inflammatory drugs (NSAIDs) should be avoided among chronic kidney disease (CKD) patients. Till now, limited data are available on NSAID use in Egypt, and we aimed to study the prevalence and pattern of NSAID use among CKD patients. METHODS: A cross-sectional study was...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353805/ https://www.ncbi.nlm.nih.gov/pubmed/30799879 http://dx.doi.org/10.1186/s42506-018-0005-2 |
_version_ | 1783391030742089728 |
---|---|
author | Abd ElHafeez, Samar Hegazy, Reem Naga, Yasmine Wahdan, Iman Sallam, Sunny |
author_facet | Abd ElHafeez, Samar Hegazy, Reem Naga, Yasmine Wahdan, Iman Sallam, Sunny |
author_sort | Abd ElHafeez, Samar |
collection | PubMed |
description | BACKGROUND: Non-steroidal anti-inflammatory drugs (NSAIDs) should be avoided among chronic kidney disease (CKD) patients. Till now, limited data are available on NSAID use in Egypt, and we aimed to study the prevalence and pattern of NSAID use among CKD patients. METHODS: A cross-sectional study was done among 350 CKD adult patients presented to the Main Alexandria University Hospital. Those with end-stage renal disease and diagnosed with acute renal injury and pregnant women were excluded. Demographic and clinical data were collected by interviewing eligible patients. Data about the pattern, history of drug-drug interactions, and knowledge about the NSAID side effects were also gathered. RESULTS: Of the enrolled patients, 57.1% were hypertensive, 46% were diabetics, 28% had osteoarthritis, and 18.3% had cardiovascular disease. CKD stages were 3.7%, 40.3%, and 56% in stages 2, 3, and 4, respectively. Almost two thirds (65.7%) were NSAID users. Among them, 82.6% were regular users. Headache was the most reported (68.7%) reason of use. The use of drugs which may have drug-drug interaction with the NSAIDs (as diuretics or renin-angiotensin-aldosterone system inhibitors) was reported in 36%. In multiple logistic regression, the odds of NSAID use decreased by 4% (odds ratio (OR) = 0.96, 95% confidence interval (CI) 0.93–0.99, p = 0.01) for every year increase in the patient’s age and decreased by 3% (OR = 0.97, 95% CI 0.95–0.99, p = 0.01) for every 1 ml/min/1.73 m(2) increase in glomerular filtration rate. CONCLUSION: Despite the hazards of NSAID use on the kidney, still high proportion of CKD patients are using them for a long period and they are simultaneously using other drugs with possible drug-drug interactions. This study provided important information that would decrease the gap in knowledge about the use of NSAID in Egypt. It is recommended that NSAIDs should be used with caution among CKD patients and patients should be advised about its adverse health consequences. |
format | Online Article Text |
id | pubmed-6353805 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-63538052019-02-21 Non-steroidal anti-inflammatory drugs among chronic kidney disease patients: an epidemiological study Abd ElHafeez, Samar Hegazy, Reem Naga, Yasmine Wahdan, Iman Sallam, Sunny J Egypt Public Health Assoc Research BACKGROUND: Non-steroidal anti-inflammatory drugs (NSAIDs) should be avoided among chronic kidney disease (CKD) patients. Till now, limited data are available on NSAID use in Egypt, and we aimed to study the prevalence and pattern of NSAID use among CKD patients. METHODS: A cross-sectional study was done among 350 CKD adult patients presented to the Main Alexandria University Hospital. Those with end-stage renal disease and diagnosed with acute renal injury and pregnant women were excluded. Demographic and clinical data were collected by interviewing eligible patients. Data about the pattern, history of drug-drug interactions, and knowledge about the NSAID side effects were also gathered. RESULTS: Of the enrolled patients, 57.1% were hypertensive, 46% were diabetics, 28% had osteoarthritis, and 18.3% had cardiovascular disease. CKD stages were 3.7%, 40.3%, and 56% in stages 2, 3, and 4, respectively. Almost two thirds (65.7%) were NSAID users. Among them, 82.6% were regular users. Headache was the most reported (68.7%) reason of use. The use of drugs which may have drug-drug interaction with the NSAIDs (as diuretics or renin-angiotensin-aldosterone system inhibitors) was reported in 36%. In multiple logistic regression, the odds of NSAID use decreased by 4% (odds ratio (OR) = 0.96, 95% confidence interval (CI) 0.93–0.99, p = 0.01) for every year increase in the patient’s age and decreased by 3% (OR = 0.97, 95% CI 0.95–0.99, p = 0.01) for every 1 ml/min/1.73 m(2) increase in glomerular filtration rate. CONCLUSION: Despite the hazards of NSAID use on the kidney, still high proportion of CKD patients are using them for a long period and they are simultaneously using other drugs with possible drug-drug interactions. This study provided important information that would decrease the gap in knowledge about the use of NSAID in Egypt. It is recommended that NSAIDs should be used with caution among CKD patients and patients should be advised about its adverse health consequences. Springer Berlin Heidelberg 2019-01-30 /pmc/articles/PMC6353805/ /pubmed/30799879 http://dx.doi.org/10.1186/s42506-018-0005-2 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Research Abd ElHafeez, Samar Hegazy, Reem Naga, Yasmine Wahdan, Iman Sallam, Sunny Non-steroidal anti-inflammatory drugs among chronic kidney disease patients: an epidemiological study |
title | Non-steroidal anti-inflammatory drugs among chronic kidney disease patients: an epidemiological study |
title_full | Non-steroidal anti-inflammatory drugs among chronic kidney disease patients: an epidemiological study |
title_fullStr | Non-steroidal anti-inflammatory drugs among chronic kidney disease patients: an epidemiological study |
title_full_unstemmed | Non-steroidal anti-inflammatory drugs among chronic kidney disease patients: an epidemiological study |
title_short | Non-steroidal anti-inflammatory drugs among chronic kidney disease patients: an epidemiological study |
title_sort | non-steroidal anti-inflammatory drugs among chronic kidney disease patients: an epidemiological study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353805/ https://www.ncbi.nlm.nih.gov/pubmed/30799879 http://dx.doi.org/10.1186/s42506-018-0005-2 |
work_keys_str_mv | AT abdelhafeezsamar nonsteroidalantiinflammatorydrugsamongchronickidneydiseasepatientsanepidemiologicalstudy AT hegazyreem nonsteroidalantiinflammatorydrugsamongchronickidneydiseasepatientsanepidemiologicalstudy AT nagayasmine nonsteroidalantiinflammatorydrugsamongchronickidneydiseasepatientsanepidemiologicalstudy AT wahdaniman nonsteroidalantiinflammatorydrugsamongchronickidneydiseasepatientsanepidemiologicalstudy AT sallamsunny nonsteroidalantiinflammatorydrugsamongchronickidneydiseasepatientsanepidemiologicalstudy |